Results 71 to 80 of about 2,463,634 (361)

Information, fidelity, and reversibility in general quantum measurements [PDF]

Phys.Rev. A93 (2016) 022104, 2015
We present the amounts of information, fidelity, and reversibility obtained by arbitrary quantum measurements on completely unknown states. These quantities are expressed as functions of the singular values of a measurement operator corresponding to the obtained outcome.
arxiv   +1 more source

Patient-Reported Outcome Measures in Cancer Care

JAMA Network Open
Key Points Question How does the integration of patient-reported outcome measures (PROMs) affect outcomes of cancer care? Findings In this update to a systematic review and meta-analysis of 45 randomized clinical trials examining the use of PROMs for ...
Amaris K Balitsky, Daniel Rayner, Joanne Britto, Anath C Lionel, Lydia Ginsberg, Wanjae Cho, Ann Mary Wilfred, Huda Sardar, Nathan Cantor, Hira Mian, Mark N Levine, Gordon H. Guyatt   +11 more
semanticscholar   +1 more source

Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? [PDF]

, 2021
Patient-reported outcome measures (PROMs), tools to assess patient self-report of health status, are now increasingly used in research, care and policymaking.
Balestro E., Bargagli E., Bendstrup E., Bocchino M., Bonella F., Cacopardo G., Calvello M., Cottin V., Kalluri M., Libra A., Luppi F., Mogulkoc N., Pavone M., Renzoni E., Torrisi S., Valenzuela C., Vancheri A., Vancheri C., Varone F., Wijsenbeek M.   +19 more
core   +4 more sources

Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional’s perspective

Supportive Care in Cancer, 2021
In the last decades, the number of cancer survivors has increased significantly due to improved treatment and better detection of recurrence. This increased survival redirects the scope from survival towards optimising functional outcomes and improving ...
Caitlin Graupner, S. Breukink, S. Mul, D. Claessens, A. Slok, M. Kimman   +5 more
semanticscholar   +1 more source

The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease

FEBS Letters, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects nearly one‐third of the global population and poses a significant risk of progression to cirrhosis or liver cancer. Here, we discuss the roles of hepatic dendritic cell subtypes in MASLD, highlighting their distinct contributions to disease initiation and progression, and their ...
Camilla Klaimi, WanTing Kong, Camille Blériot, Joel T. Haas   +3 more
wiley   +1 more source

The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: a systematic review of reviews

Journal of Patient-Reported Outcomes, 2018
BackgroundThere is increasing interest in using Patient Reported Outcome Measures (PROMs) within organisations delivering health related services. However, organisations have had mixed success in implementing PROMs and there is little understanding about
Alexis Foster, L. Croot, J. Brazier, Janet Harris, A. O’Cathain   +4 more
semanticscholar   +1 more source

Taurine promotes glucagon‐like peptide‐1 secretion in enteroendocrine L cells

FEBS Letters, EarlyView.
Taurine, a sulfur‐containing amino acid, is likely taken up by enteroendocrine L cells via the taurine transporter. This process increases the levels of cytosolic ATP. The increase in intracellular Ca2+ concentrations and glucagon‐like peptide‐1 secretion through membrane depolarization is caused by the closure of ATP‐sensitive potassium channels ...
Yuri Osuga, Kazuki Harada, Takuya Yamauchi, Tetsuya Kitaguchi, Masami Yokota Hirai, Mitsuharu Matsumoto, Takashi Tsuboi   +6 more
wiley   +1 more source

Patient-Reported Outcome Measures in Routine Pediatric Clinical Care: A Systematic Review

Frontiers in Pediatrics, 2020
Introduction: Integration of patient-reported outcome measures (PROMs) in routine clinical care is growing but lacks consolidated evidence around its impact on pediatric care.
S. Bele, Ashton Chugh, Bijan Mohamed, L. Teela, L. Haverman, M. Santana   +5 more
semanticscholar   +1 more source

Making tau amyloid models in vitro: a crucial and underestimated challenge

FEBS Letters, EarlyView.
This review highlights the challenges of producing in vitro amyloid assemblies of the tau protein. We review how accurately the existing protocols mimic tau deposits found in the brain of patients affected with tauopathies. We discuss the important properties that should be considered when forming amyloids and the benchmarks that should be used to ...
Julien Broc, Clara Piersson, Yann Fichou
wiley   +1 more source

The survival-incorporated median versus the median in the survivors or in the always-survivors: What are we measuring? And why? [PDF]

arXiv, 2021
Many clinical studies evaluate the benefit of a treatment based on both survival and other continuous/ordinal clinical outcomes, such as Quality of Life scores. In these studies, when subjects die before the follow-up assessment, the clinical outcomes become undefined and are truncated by death. Treating outcomes as "missing" or "censored" due to death
arxiv